Showing results (301-310 of 363) with videos related to
Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive TrialsMax Kates, Andres Matoso, Woonyoung Choi, et al.European Urology Focus|January 29, 2023
Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic ReviewLuca Antonelli, Kirby Sebro, Abdelilah Lahmar, et al.The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.Journal of Patient-Reported Outcomes|March 27, 2025
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SIClaudia Rutherford, Margaret-Ann Tait, Daniel S J Costa, et al.European Urology Oncology|April 25, 2019
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder CancerStephen B Williams, Hogan K Hudgins, Mohamed D Ray-Zack, et al.Pathology Oncology Research : POR|August 6, 2020
Prevalence of APC and PTEN Alterations in Urachal CancerNikolett Nagy, Henning Reis, Boris Hadaschik, et al.European Urology|March 14, 2020
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder CancerAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.The Journal of Urology|October 29, 2024
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder CancerEunice Villegas, Katherine Lajkosz, Shayan Din, et al.European Urology Focus|February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.Cancer Medicine|January 21, 2023
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomasMelinda Varadi, Nikolett Nagy, Henning Reis, et al.Pageof 37